Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Frequency of stent thrombosis after acute coronary syndromes (from the symphony and 2nd symphony trials)

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Tolleson, T. R.
  • Newby, L. K.
  • Harrington, R. A.
  • Bhapkar, M. V.
  • Verheught, F. W. A.
  • Berger, P. B.
  • Moliterno, D. J.
  • White, H. D.
  • Ohman, E. M.
  • Van de Werf, F.
  • Topol, Eric
  • Califf, R. M.
  • Investigators, Symphony
  • Investigators, 2nd Symphony

publication date

  • 2003

journal

  • American Journal of Cardiology  Journal

abstract

  • We studied stent thrombosis in 4,607 patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention. In these patients, stent thrombosis occurred more often than in previous patients who underwent elective percutaneous coronary intervention. These patients and their outcomes may be more representative of patients with typical acute coronary syndromes undergoing stenting in clinical practice.

subject areas

  • Acute Disease
  • Aspirin
  • Causality
  • Coronary Disease
  • Coronary Thrombosis
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Ischemia
  • Oximes
  • Piperidines
  • Platelet Aggregation Inhibitors
  • Postoperative Complications
  • Stents
  • Syndrome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0002-9149

Digital Object Identifier (DOI)

  • 10.1016/s0002-9149(03)00641-6

PubMed ID

  • 12888148
scroll to property group menus

Additional Document Info

start page

  • 330

end page

  • 333

volume

  • 92

issue

  • 3

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support